Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cho Pharma Inc.

Clinical trials sponsored by Cho Pharma Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for tough lymphoma: experimental drug CHO-H01 enters human trials Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New hope for tough lymphoma: experimental drug CHO-H01 enters human trials

Disease control Ongoing

This study tests an experimental drug called CHO-H01, alone or with lenalidomide, in people with non-Hodgkin lymphoma that has returned or not responded to prior treatments. The trial has two parts: first, finding a safe dose of CHO-H01 alone; second, testing the combination in l…

Phase 1/2 • Sponsor: Cho Pharma Inc. • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC